October 28, 2016
Alexion starts phase 3 trials for two ultra-rare diseases
Alexion Pharmaceuticals has announced the initiation of two Phase 3 trials of ALXN1210…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Martin Mackay